Effects of a new 2-piperazinotetralin on alpha-1 and alpha-2 adrenergic receptors in isolated rat vas deferens. 1985

V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov

The pharmacological action of a newly synthesized piperazine derivative of 2-aminotetralin (P11) on pre- and postsynaptic alpha-adrenoceptors of isolated rat vas deferens has been investigated. P11 shifted noradrenaline concentration-effect curves to the right. The pA2 value was 5.88 for P11, 5.38 for phentolamine, and 7.73 for prazosin. The maximum effect of the agonist was enhanced by P11 and phentolamine, but this enhancement was less pronounced in the presence of 1 X 10(-5) M cocaine and 1 X 10(-6) M propranolol. 1 X 10(-6) M to 1 X 10(-5) M P11 increased the contractions of a field-stimulated vas deferens and antagonized the effects of clonidine (1 X 10(-9) M on the same preparation. The IC50 values of P11, phentolamine and prazosin were 0.40 microM, 0.03 microM and greater than 10.0 microM, respectively. The results show that P11 possesses alpha 1-and alpha 2-adrenolytic activity. The effect of P11 on these receptors most likely participates in the mechanisms of its hypotensive action.

UI MeSH Term Description Entries
D008297 Male Males
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
March 1983, Molecular pharmacology,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
January 1984, Advances in experimental medicine and biology,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
January 1984, Molecular pharmacology,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
June 1981, Japanese journal of pharmacology,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
February 1987, The Journal of pharmacology and experimental therapeutics,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
June 1970, Archives internationales de pharmacodynamie et de therapie,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
February 1984, Fukushima journal of medical science,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
October 1982, Japanese journal of pharmacology,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
January 1994, British journal of pharmacology,
V Mutafova-Yambolieva, and D Staneva-Stoytcheva, and D Ivanov
June 1985, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!